Results 141 to 150 of about 193,847 (359)

Activation of Meiotic Maturation in Rat Oocytes After Treatment with Follicular Fluid Meiosis-Activating Sterol In Vitro and Ex Vivo [PDF]

open access: bronze, 2001
Christa Hegele‐Hartung   +5 more
openalex   +1 more source

Rational Design of Ni3+‐Rich Nickel Nitride Enables Paired Electrooxidation of Sterol and Hydrogen Evolution in a Flow Electrolyzer

open access: yesAdvanced Science
Electrooxidation of sterols is recognized as a promising approach for synthesizing value‐added steroid hormone pharmaceuticals. However, enhancing current density while delivering market‐required steroidal carbonyl products with high selectivity remains ...
Suiqin Li   +11 more
doaj   +1 more source

Quantitative isolation of sterols

open access: yesJournal of Lipid Research, 1963
Procedures are described for the quantitative gravimetric isolation of cholesterol and cholestan-3β-01 as the digitonides and for the quantitative recovery of these sterols from their digitonides in the range of 0.5-4.0 mg.
openaire   +3 more sources

Metabolic Signatures and Diagnostic Prediction Models for Coronary Artery Disease and Type 2 Diabetes Mellitus: Insights From an Exploratory Study

open access: yesiNew Medicine, EarlyView.
Metabolomic & lipidomic analysis reveals metabolic overlap between CAD & T2DM, highlighting 7 key metabolites as potential biomarkers. A predictive model based on these achieves high accuracy, potentially advancing precision medicine & metabolic insights.
Zhihua Wang   +9 more
wiley   +1 more source

Small molecule inhibitors targeting sterol 14α-demethylase (CYP51): synthesis, molecular modeling and evaluation against Candida albicans

open access: gold, 2020
Faizah A. Binjubair   +5 more
openalex   +1 more source

Microbial conversion of sterol‐containing soybean oil production waste [PDF]

open access: bronze, 2004
Marina V. Donova   +6 more
openalex   +1 more source

N6‐Methyladenosine (m6A) in Liver Disease: Pathogenic Mechanisms and Therapeutic Potential

open access: yesiNew Medicine, EarlyView.
ABSTRACT Accumulating evidence highlights the critical role of epigenetic modifications, particularly N6‐methyladenosine (m6A), in liver disease. As the most abundant RNA modification in eukaryotic cells, m6A is dynamically regulated by multicomponent m6A methyltransferases (e.g., METTL3 and METTL14), demethylases (FTO and ALKBH5), and m6A‐binding ...
Yingfen Chen   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy